about
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development...
Read More
23.92
0.76
(3.28%)
947.0K
XNAS Volume
XNAS 13 Jan, 2026 4:30 PM (EST)
Board Meeting
The board meeting for Zymeworks BC Inc is scheduled for today, for the purpose of Zymeworks Inc J.P. Morgan Healthcare Conference Presentation and Webcast
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Zymeworks BC Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..